Precision Business Insights
Portfolio

 

Research Reports

Organ and Tissue Transplantation Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024

Global Organ and Tissue Transplantation Market

 

By Product (Immunosuppressants, Preservation Solutions, and Tissue Products) By Application (Organ Transplantation, Tissue Transplantation), By End User (Hospitals, Transplantation Centers, Others), and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

Global organ and tissue transplantation market was valued at US $ XX Mn in 2017 and expected to grow at XX% Compound Annual Growth Rate (CAGR) over 2018 to 2024

 

Market Outline: Organ and Tissue Transplantation Market

Organ and tissue transplantation saves many lives and restores the essential functions of the body. The organ transplantation is the medical procedure in which the organ is removed from one body and is placed in the recipient’s body. The organs which can be transplanted include kidneys, heart, intestine, thymus, liver, lings and pancreas. The tissues include skin, cornea, heart valve, tendons and bones. The organ failure generally occurs owing to several conditions such as poising, serious trauma, drug abuse, and so on. The organ transplantation is the final stage of the treatment in organ failure.

 

Market Dynamics: Organ and Tissue Transplantation Market

Increase in the prevalence of chronic diseases and rising organ and tissue transplantation owing to organ damage or impairment is the key factor driving the growth of the organ and tissue transplantation market. The improving technology for organ and tissue transportation and transplantation is adding fuel for the growth of the market. The increasing investments in the research and development is providing opportunity for the growth of the organ and tissue transplantation market. However, the increasing incidence of the organ failures post-surgery is hampering the growth of the market. The limited number of donors is also and high cost involved in the treatment is expected to restrain the growth of the organ and tissue transplantation market. Lack of awareness regarding the organ donation is likely to constrain the growth of the market.

 

Market Scope: Organ and Tissue Transplantation Market

Organ and tissue transplantation market is segmented based on the application and distribution channel

Based on the product type, the market is segmented into the following:

  • Immunosuppressants
  • Preservation Solutions
  • Tissue Products

Based on the application, the market is segmented into the following:

  • Organ Transplantation
    • Heart
    • Lungs
    • Liver
    • Kidney
    • Intestine/Small Bowel
    • Pancreas
  • Tissue Transplantation
    • Skin Transplantation
    • Cellular Transplantation
    • Cornea
    • Vascular Transplantation
    • Bone Graft Transplantation

Based on the end user, the market is segmented into the following:

  • Hospitals
  • Transplantation Centers
  • Others

 

Regional Analysis:  Organ and Tissue Transplantation Market

Geographically, global organ and tissue transplantation market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America organ and tissue transplantation market growth is driven advanced technology. The increasing prevalence of the chronic diseases such as diabetes may cause renal failure which require organ transplantation. As per the National Kidney Foundation, there were approximately 122,737 patients waiting for the transplantation of their organs in the U.S. Following the North America, are the regions of Europe and Asia Pacific. The Asia Pacific expected to grow at significant rate over the forecast period owing to its developing economy and huge patient pool.

 

Competition Assessment: Organ and Tissue Transplantation Market

Some of the players in the global organ and tissue transplantation market include:

  • Hoffmann-La Roche Ltd. (Switzerland)
  • Novartis International AG (Switzerland)
  • OrganOX Limited (UK)
  • Terumo Medical Corporation (US)
  • Transonic (US)
  • Bio Med Pvt. Ltd. (US)
  • Transplant Biomedical (UK)
  • GlaxoSmithKline Plc. (UK)
  • Accord Healthcare GmbH (Spain)
  • Sanofi (France)
  • Pfizer, Inc. (US)

 

Notable Market Developments: Organ and Tissue Transplantation Market

  • In April 2017, Sanofi has received FDA Approval of Thymoglobulin for the Prevention of Acute Kidney Transplant Rejection

 

Key Features of the Report:

  • The report covers exhaustive regional information, that includes North America (the USA and Canada), Europe (Germany, France, Italy, UK, Spain, Russia, Poland and Rest of Europe), Asia-Pacific (Japan, China, India, Australia & New Zealand, ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others), South Korea, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Argentian, Venezula, and Rest of Latin America), and Middle East and Africa (Gulf Cooperation Council (GCC) Countries, Israel, South Africa, and Rest of Middle East and Africa)
  • The report provides granular level information about the market size, regional market share, historic market (2013-2017) and forecast (2018-2024)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
  • Hoffmann-La Roche Ltd. (Switzerland)
  • Novartis International AG (Switzerland)
  • OrganOX Limited (UK)
  • Terumo Medical Corporation (US)
  • Transonic (US)
  • Bio Med Pvt. Ltd. (US)
  • Transplant Biomedical (UK)
  • GlaxoSmithKline Plc. (UK)
  • Accord Healthcare GmbH (Spain)
  • Sanofi (France)
  • Pfizer, Inc. (US)

A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements

 

$ 3,000.00$ 8,900.00
Clear selection

Select License Type

Databank $ 3,000.00
spinner
Single User $ 4,400.00
spinner
Multiple User $ 6,600.00
spinner
Corporate User $ 8,900.00
spinner
buy now spinner
FacebookTwitterLinkedinEmail

Our Clients

Testimonials